 Emily DeBoer
Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 9 | 2026 | 534 | 3.790 |
Why?
| | Deglutition Disorders | 7 | 2025 | 147 | 2.370 |
Why?
| | Bronchiectasis | 5 | 2024 | 112 | 2.290 |
Why?
| | Esophageal Atresia | 4 | 2022 | 30 | 2.000 |
Why?
| | Tracheoesophageal Fistula | 4 | 2022 | 38 | 1.980 |
Why?
| | Lung Diseases, Interstitial | 7 | 2024 | 660 | 1.810 |
Why?
| | Bronchoscopy | 8 | 2021 | 227 | 1.560 |
Why?
| | Cystic Fibrosis | 7 | 2022 | 1158 | 1.310 |
Why?
| | Lung Diseases | 3 | 2025 | 787 | 1.280 |
Why?
| | Lung | 13 | 2025 | 4109 | 1.220 |
Why?
| | Child | 39 | 2026 | 22633 | 1.210 |
Why?
| | Tomography, X-Ray Computed | 10 | 2025 | 2730 | 1.100 |
Why?
| | Oscillometry | 2 | 2025 | 35 | 1.050 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2019 | 636 | 0.980 |
Why?
| | Computer Simulation | 3 | 2021 | 1025 | 0.980 |
Why?
| | Idiopathic Pulmonary Fibrosis | 5 | 2026 | 691 | 0.950 |
Why?
| | Respiratory System Abnormalities | 1 | 2025 | 18 | 0.920 |
Why?
| | Proteomics | 5 | 2023 | 1195 | 0.910 |
Why?
| | Airway Resistance | 2 | 2025 | 38 | 0.910 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2025 | 300 | 0.830 |
Why?
| | Child, Preschool | 19 | 2026 | 11787 | 0.800 |
Why?
| | Delphi Technique | 2 | 2024 | 329 | 0.760 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2023 | 140 | 0.760 |
Why?
| | Airway Obstruction | 2 | 2021 | 162 | 0.750 |
Why?
| | Respiratory Tract Infections | 2 | 2026 | 397 | 0.730 |
Why?
| | Resilience, Psychological | 1 | 2024 | 152 | 0.720 |
Why?
| | Respiration Disorders | 2 | 2020 | 77 | 0.700 |
Why?
| | Hydrodynamics | 1 | 2021 | 47 | 0.680 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2021 | 45 | 0.670 |
Why?
| | Protein C | 1 | 2021 | 53 | 0.660 |
Why?
| | Burnout, Professional | 2 | 2024 | 484 | 0.640 |
Why?
| | Deglutition | 5 | 2025 | 72 | 0.640 |
Why?
| | Infant | 14 | 2026 | 10034 | 0.640 |
Why?
| | Heart Diseases | 1 | 2023 | 349 | 0.610 |
Why?
| | Intellectual Disability | 1 | 2021 | 175 | 0.600 |
Why?
| | Autoimmune Diseases | 1 | 2024 | 463 | 0.600 |
Why?
| | Gastrointestinal Diseases | 2 | 2018 | 216 | 0.600 |
Why?
| | Humans | 54 | 2026 | 144759 | 0.600 |
Why?
| | Tomography | 2 | 2021 | 45 | 0.590 |
Why?
| | Models, Anatomic | 2 | 2020 | 84 | 0.580 |
Why?
| | Air | 1 | 2018 | 45 | 0.550 |
Why?
| | Retrospective Studies | 17 | 2026 | 17066 | 0.550 |
Why?
| | Vascular Diseases | 1 | 2020 | 251 | 0.540 |
Why?
| | Aptamers, Nucleotide | 1 | 2019 | 85 | 0.540 |
Why?
| | Health Status | 1 | 2023 | 836 | 0.540 |
Why?
| | Respiration | 1 | 2018 | 206 | 0.520 |
Why?
| | Trachea | 4 | 2020 | 261 | 0.510 |
Why?
| | Sleep Wake Disorders | 1 | 2020 | 301 | 0.500 |
Why?
| | Hospitalization | 1 | 2026 | 2433 | 0.470 |
Why?
| | Tracheomalacia | 3 | 2020 | 17 | 0.450 |
Why?
| | Pneumonia | 1 | 2021 | 631 | 0.450 |
Why?
| | Adolescent | 17 | 2026 | 22428 | 0.440 |
Why?
| | Male | 26 | 2026 | 72315 | 0.430 |
Why?
| | Bronchi | 1 | 2015 | 267 | 0.410 |
Why?
| | Gastroesophageal Reflux | 2 | 2015 | 236 | 0.410 |
Why?
| | Female | 26 | 2026 | 78271 | 0.400 |
Why?
| | Automation | 1 | 2014 | 102 | 0.400 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 780 | 0.400 |
Why?
| | Models, Biological | 1 | 2021 | 1821 | 0.400 |
Why?
| | Respiratory Tract Diseases | 3 | 2019 | 175 | 0.380 |
Why?
| | Indoles | 3 | 2026 | 501 | 0.370 |
Why?
| | Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2012 | 5 | 0.360 |
Why?
| | Young Adult | 8 | 2026 | 14105 | 0.350 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1980 | 0.350 |
Why?
| | Esophagoscopy | 3 | 2019 | 221 | 0.340 |
Why?
| | Models, Statistical | 1 | 2015 | 681 | 0.340 |
Why?
| | Twins, Monozygotic | 1 | 2012 | 134 | 0.340 |
Why?
| | Diseases in Twins | 1 | 2012 | 115 | 0.340 |
Why?
| | Family Health | 1 | 2012 | 191 | 0.340 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3863 | 0.320 |
Why?
| | Patient Readmission | 1 | 2016 | 758 | 0.320 |
Why?
| | Electric Impedance | 3 | 2021 | 111 | 0.310 |
Why?
| | Asthma | 1 | 2021 | 1767 | 0.300 |
Why?
| | Referral and Consultation | 1 | 2015 | 851 | 0.300 |
Why?
| | Neuroendocrine Cells | 2 | 2019 | 33 | 0.290 |
Why?
| | Eosinophilic Esophagitis | 3 | 2019 | 330 | 0.290 |
Why?
| | Respiratory Function Tests | 2 | 2025 | 547 | 0.280 |
Why?
| | Thoracoscopy | 2 | 2019 | 62 | 0.280 |
Why?
| | Electronic Health Records | 1 | 2016 | 1173 | 0.270 |
Why?
| | Internship and Residency | 1 | 2018 | 1257 | 0.260 |
Why?
| | Case-Control Studies | 3 | 2019 | 3604 | 0.240 |
Why?
| | Patient Care Team | 2 | 2024 | 689 | 0.230 |
Why?
| | Prospective Studies | 4 | 2025 | 7990 | 0.220 |
Why?
| | Albuterol | 1 | 2025 | 73 | 0.220 |
Why?
| | Heart Defects, Congenital | 2 | 2025 | 914 | 0.210 |
Why?
| | Polysomnography | 1 | 2025 | 235 | 0.210 |
Why?
| | Respiratory Rate | 1 | 2023 | 23 | 0.200 |
Why?
| | Postoperative Complications | 1 | 2016 | 2919 | 0.200 |
Why?
| | Infant, Newborn | 5 | 2025 | 6429 | 0.200 |
Why?
| | Gastroenterology | 2 | 2023 | 189 | 0.190 |
Why?
| | Disease Progression | 4 | 2024 | 2847 | 0.190 |
Why?
| | Vital Capacity | 3 | 2024 | 290 | 0.190 |
Why?
| | Hyperplasia | 2 | 2019 | 174 | 0.180 |
Why?
| | Pediatricians | 1 | 2023 | 121 | 0.180 |
Why?
| | Respiratory System Agents | 1 | 2022 | 23 | 0.180 |
Why?
| | Aspergillosis, Allergic Bronchopulmonary | 1 | 2021 | 11 | 0.180 |
Why?
| | Insufflation | 1 | 2021 | 13 | 0.180 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2024 | 237 | 0.170 |
Why?
| | Laryngoscopy | 2 | 2020 | 117 | 0.170 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2021 | 18 | 0.170 |
Why?
| | Medicine | 1 | 2023 | 125 | 0.170 |
Why?
| | Pulmonary Ventilation | 1 | 2021 | 83 | 0.170 |
Why?
| | Prognosis | 2 | 2024 | 4282 | 0.170 |
Why?
| | Job Satisfaction | 1 | 2023 | 240 | 0.160 |
Why?
| | Spirometry | 1 | 2021 | 231 | 0.160 |
Why?
| | Surface-Active Agents | 1 | 2021 | 92 | 0.160 |
Why?
| | Severity of Illness Index | 2 | 2025 | 2925 | 0.160 |
Why?
| | Bronchodilator Agents | 1 | 2021 | 182 | 0.160 |
Why?
| | Laryngoscopes | 1 | 2020 | 45 | 0.150 |
Why?
| | Protein Kinase Inhibitors | 1 | 2026 | 969 | 0.150 |
Why?
| | Aminophenols | 1 | 2022 | 201 | 0.150 |
Why?
| | Adult | 6 | 2024 | 40449 | 0.150 |
Why?
| | Heart | 1 | 2023 | 636 | 0.150 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5868 | 0.150 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2019 | 16 | 0.150 |
Why?
| | Digestive System Diseases | 1 | 2019 | 27 | 0.150 |
Why?
| | Ultrasonography | 1 | 2023 | 770 | 0.150 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 22 | 0.140 |
Why?
| | Comorbidity | 2 | 2020 | 1658 | 0.140 |
Why?
| | Consensus | 1 | 2020 | 488 | 0.140 |
Why?
| | Equipment Design | 1 | 2020 | 530 | 0.140 |
Why?
| | Prevalence | 1 | 2025 | 2834 | 0.140 |
Why?
| | Formative Feedback | 1 | 2018 | 31 | 0.140 |
Why?
| | Esophageal Mucosa | 1 | 2018 | 22 | 0.130 |
Why?
| | Bronchiolitis Obliterans | 1 | 2018 | 66 | 0.130 |
Why?
| | Diet | 1 | 2025 | 1273 | 0.130 |
Why?
| | Virtual Reality | 1 | 2019 | 77 | 0.130 |
Why?
| | Biomarkers | 2 | 2019 | 4271 | 0.130 |
Why?
| | Sleep | 1 | 2024 | 901 | 0.130 |
Why?
| | Phenotype | 1 | 2025 | 3162 | 0.120 |
Why?
| | Caregivers | 1 | 2025 | 1049 | 0.120 |
Why?
| | Hospitals, Pediatric | 2 | 2019 | 556 | 0.120 |
Why?
| | Gastrostomy | 1 | 2018 | 130 | 0.120 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 265 | 0.120 |
Why?
| | Patient-Centered Care | 1 | 2021 | 544 | 0.120 |
Why?
| | Pediatrics | 1 | 2024 | 1114 | 0.120 |
Why?
| | Program Development | 1 | 2018 | 370 | 0.110 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 299 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1489 | 0.110 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2015 | 34 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 197 | 0.110 |
Why?
| | Respiration, Artificial | 1 | 2020 | 708 | 0.110 |
Why?
| | Demography | 1 | 2015 | 288 | 0.110 |
Why?
| | Patient Satisfaction | 2 | 2019 | 704 | 0.110 |
Why?
| | Long-Term Care | 1 | 2015 | 117 | 0.110 |
Why?
| | Anesthesia | 1 | 2018 | 258 | 0.110 |
Why?
| | Larynx | 1 | 2014 | 56 | 0.100 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 583 | 0.100 |
Why?
| | Diagnostic Imaging | 1 | 2016 | 338 | 0.100 |
Why?
| | ROC Curve | 1 | 2015 | 614 | 0.100 |
Why?
| | Congenital Abnormalities | 1 | 2014 | 104 | 0.100 |
Why?
| | Mutation | 2 | 2022 | 4089 | 0.100 |
Why?
| | United States | 3 | 2023 | 15966 | 0.100 |
Why?
| | Inflammation | 2 | 2022 | 2878 | 0.100 |
Why?
| | Ambulatory Care | 1 | 2018 | 600 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3409 | 0.100 |
Why?
| | Quality of Life | 1 | 2025 | 3185 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1694 | 0.090 |
Why?
| | Genes, Recessive | 1 | 2012 | 78 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2012 | 307 | 0.080 |
Why?
| | Fibrosis | 2 | 2024 | 548 | 0.080 |
Why?
| | Logistic Models | 1 | 2015 | 2117 | 0.080 |
Why?
| | Endoscopy, Digestive System | 2 | 2024 | 140 | 0.080 |
Why?
| | Clinical Competence | 1 | 2018 | 1244 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4564 | 0.080 |
Why?
| | Esophagus | 2 | 2024 | 261 | 0.070 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 676 | 0.070 |
Why?
| | Survival Rate | 1 | 2014 | 2089 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5408 | 0.070 |
Why?
| | Body Mass Index | 1 | 2017 | 2438 | 0.070 |
Why?
| | Algorithms | 1 | 2015 | 1837 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1289 | 0.060 |
Why?
| | Time Factors | 2 | 2019 | 7173 | 0.060 |
Why?
| | Sex Factors | 1 | 2012 | 2112 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2021 | 1095 | 0.060 |
Why?
| | Diarrhea | 1 | 2026 | 192 | 0.060 |
Why?
| | Biopsy | 2 | 2019 | 1075 | 0.050 |
Why?
| | Calreticulin | 1 | 2022 | 22 | 0.050 |
Why?
| | HMGB Proteins | 1 | 2022 | 17 | 0.050 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 40 | 0.050 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2022 | 89 | 0.040 |
Why?
| | Aspergillus fumigatus | 1 | 2021 | 25 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2024 | 433 | 0.040 |
Why?
| | Risk Factors | 1 | 2016 | 10779 | 0.040 |
Why?
| | Lung Volume Measurements | 1 | 2021 | 46 | 0.040 |
Why?
| | Patient Compliance | 1 | 2025 | 588 | 0.040 |
Why?
| | Leptin | 1 | 2022 | 245 | 0.040 |
Why?
| | Needles | 1 | 2020 | 62 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 319 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2020 | 215 | 0.040 |
Why?
| | Quinolones | 1 | 2022 | 201 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 112 | 0.040 |
Why?
| | Pressure | 1 | 2020 | 225 | 0.040 |
Why?
| | Noninvasive Ventilation | 1 | 2020 | 62 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 96 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2025 | 684 | 0.040 |
Why?
| | Speech-Language Pathology | 1 | 2019 | 23 | 0.040 |
Why?
| | Pseudomonas aeruginosa | 1 | 2021 | 356 | 0.040 |
Why?
| | Fluoroscopy | 1 | 2019 | 176 | 0.040 |
Why?
| | Social Support | 1 | 2023 | 652 | 0.040 |
Why?
| | Pulmonary Medicine | 1 | 2019 | 79 | 0.030 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 370 | 0.030 |
Why?
| | Bronchioles | 1 | 2018 | 29 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 139 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2026 | 11679 | 0.030 |
Why?
| | Interdisciplinary Research | 1 | 2018 | 26 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2023 | 2029 | 0.030 |
Why?
| | Emotions | 1 | 2023 | 578 | 0.030 |
Why?
| | Rare Diseases | 1 | 2018 | 113 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 121 | 0.030 |
Why?
| | Otolaryngology | 1 | 2019 | 108 | 0.030 |
Why?
| | Proteome | 1 | 2022 | 518 | 0.030 |
Why?
| | Anesthetics | 1 | 2018 | 99 | 0.030 |
Why?
| | Lipids | 1 | 2022 | 710 | 0.030 |
Why?
| | Endoscopy | 1 | 2019 | 316 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1135 | 0.030 |
Why?
| | Perioperative Care | 1 | 2018 | 231 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2018 | 255 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1886 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 396 | 0.030 |
Why?
| | Mouth | 1 | 2015 | 88 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 645 | 0.030 |
Why?
| | Respiratory Aspiration | 1 | 2014 | 32 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 948 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1053 | 0.030 |
Why?
| | Animals | 1 | 2016 | 38058 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2019 | 691 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 134 | 0.020 |
Why?
| | Research Design | 1 | 2019 | 1135 | 0.020 |
Why?
| | Middle Aged | 1 | 2014 | 35875 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 6048 | 0.020 |
Why?
|
|
DeBoer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|